Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients
View abstract on PubMed
Summary
This summary is machine-generated.The COVID-19 pandemic reduced non-emergency cancer diagnoses in Scotland, increasing emergency presentations for some cancers. This shift suggests lost opportunities for early cancer detection and favorable outcomes.
Area Of Science
- Oncology
- Public Health
- Epidemiology
Background
- The COVID-19 pandemic significantly disrupted routine cancer diagnosis pathways.
- This disruption particularly affected screening and non-acute symptomatic cancer cases.
- Differential impacts on emergency cancer presentations, linked to poorer outcomes, were not well-described.
Purpose Of The Study
- To analyze the impact of the COVID-19 pandemic on cancer diagnosis routes in Scotland.
- To compare changes in non-emergency versus emergency cancer diagnoses during the pandemic.
- To assess the persistence of these changes into 2021.
Main Methods
- A cross-sectional descriptive study utilized International Cancer Benchmarking Partnership methods.
- Data spanned from 2015 to 2021, linking acute hospital records and national cancer registry data.
- Emergency diagnosis was defined as presentation within 30 days prior to cancer incidence date.
Main Results
- Non-emergency cancer diagnoses decreased significantly in 2020 for all studied cancers, with partial recovery in 2021.
- Colorectal and cervical cancers saw the largest non-emergency diagnosis reductions (approx. one-third) in 2020.
- Emergency diagnoses increased for breast, cervical, colorectal, and upper GI cancers in 2020, and for breast and cervical cancers in 2021.
Conclusions
- The pandemic led to substantial reductions in elective cancer diagnoses in Scotland in 2020.
- Emergency cancer diagnoses decreased only for prostate cancer during this period.
- These diagnostic shifts suggest missed opportunities for favorable cancer diagnosis, with some effects continuing into 2021.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Descriptive Statistics: These provide basic...
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Predicting Outbreaks
Predictive analytics, a branch of statistics, uses historical data, algorithmic models, and...

